Role of Adverse Events Supervision in Clinical Trials in Neoadjuvant Treatment of Operable Stage III NSCLC
Background and objective Programmed cell death protein 1 (PD-1) combined with platinum containing dual drug chemotherapy is a new adjuvant treatment option for operable stage III non-small cell lung cancer (NSCLC), and the quality assurance of clinical trials of related drugs plays a crucial role in...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Chinês |
| Baskı/Yayın Bilgisi: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-06-01
|
| Seri Bilgileri: | Chinese Journal of Lung Cancer |
| Konular: | |
| Online Erişim: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.23 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|